tiprankstipranks
Trending News
More News >
Chugai Pharmaceutical Co Ltd (JP:4519)
:4519
Japanese Market
Advertisement

Chugai Pharmaceutical Co (4519) Ratios

Compare
3 Followers

Chugai Pharmaceutical Co Ratios

JP:4519's free cash flow for Q2 2025 was ¥0.70. For the 2025 fiscal year, JP:4519's free cash flow was decreased by ¥ and operating cash flow was ¥0.47. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
6.04 4.74 3.15 3.25 3.54
Quick Ratio
5.16 3.79 2.46 2.61 2.76
Cash Ratio
1.85 1.59 0.52 0.82 0.90
Solvency Ratio
1.36 1.16 0.91 0.95 0.96
Operating Cash Flow Ratio
1.73 1.42 0.58 0.85 0.87
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 1.33T¥ 1.06T¥ 891.17B¥ 712.98B¥ 579.41B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 0.01 0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 0.01 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.15 1.19 1.31 1.30 1.26
Debt Service Coverage Ratio
0.00 0.00 6.65K 6.96K 3.96K
Interest Coverage Ratio
0.00 0.00 8.74K 8.79K 4.86K
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
8.02 8.18 8.62 9.78 6.90
Net Debt to EBITDA
-0.87 -0.94 -0.37 -0.56 -0.61
Profitability Margins
Gross Profit Margin
70.37%62.81%62.20%66.18%65.25%
EBIT Margin
46.49%39.94%42.33%41.95%37.90%
EBITDA Margin
46.73%42.80%44.66%45.04%41.77%
Operating Profit Margin
47.06%39.52%42.33%42.20%38.28%
Pretax Profit Margin
46.49%39.93%42.16%41.95%37.89%
Net Profit Margin
33.06%29.29%29.72%30.31%27.29%
Continuous Operations Profit Margin
33.06%29.29%29.72%30.31%27.29%
Net Income Per EBT
71.11%73.33%70.49%72.25%72.01%
EBT Per EBIT
98.80%101.06%99.60%99.40%98.99%
Return on Assets (ROA)
17.36%16.84%20.03%19.69%17.38%
Return on Equity (ROE)
20.83%20.02%26.29%25.50%21.91%
Return on Capital Employed (ROCE)
28.01%26.71%36.88%34.83%30.14%
Return on Invested Capital (ROIC)
19.91%19.59%26.00%25.16%21.70%
Return on Tangible Assets
17.62%17.02%20.30%19.98%17.72%
Earnings Yield
3.72%3.70%6.76%4.93%2.37%
Efficiency Ratios
Receivables Turnover
3.77 3.49 2.46 2.81 3.11
Payables Turnover
4.52 7.62 2.27 2.22 2.72
Inventory Turnover
1.50 1.51 1.63 1.62 1.49
Fixed Asset Turnover
2.54 2.64 3.26 2.84 2.65
Asset Turnover
0.53 0.58 0.67 0.65 0.64
Working Capital Turnover Ratio
0.90 1.12 1.53 1.50 1.41
Cash Conversion Cycle
258.52 298.35 211.61 191.04 228.96
Days of Sales Outstanding
96.71 104.73 148.48 129.97 117.51
Days of Inventory Outstanding
242.56 241.52 223.95 225.42 245.45
Days of Payables Outstanding
80.76 47.90 160.82 164.36 134.00
Operating Cycle
339.28 346.25 372.43 355.40 362.96
Cash Flow Ratios
Operating Cash Flow Per Share
282.01 249.16 148.41 170.07 124.76
Free Cash Flow Per Share
241.44 204.03 105.10 125.75 87.39
CapEx Per Share
40.57 45.14 43.31 44.32 37.37
Free Cash Flow to Operating Cash Flow
0.86 0.82 0.71 0.74 0.70
Dividend Paid and CapEx Coverage Ratio
2.03 1.99 1.17 1.63 1.34
Capital Expenditure Coverage Ratio
6.95 5.52 3.43 3.84 3.34
Operating Cash Flow Coverage Ratio
35.15 30.47 17.30 17.43 18.17
Operating Cash Flow to Sales Ratio
0.39 0.37 0.19 0.28 0.26
Free Cash Flow Yield
3.74%3.82%3.12%3.37%1.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
27.13 27.00 14.80 20.27 42.12
Price-to-Sales (P/S) Ratio
8.97 7.91 4.40 6.14 11.49
Price-to-Book (P/B) Ratio
5.41 5.41 3.89 5.17 9.23
Price-to-Free Cash Flow (P/FCF) Ratio
27.00 26.18 32.04 29.70 62.97
Price-to-Operating Cash Flow Ratio
23.12 21.44 22.69 21.96 44.11
Price-to-Earnings Growth (PEG) Ratio
-7.56 -2.06 0.63 0.49 1.16
Price-to-Fair Value
5.41 5.41 3.89 5.17 9.23
Enterprise Value Multiple
18.33 17.54 9.48 13.08 26.90
Enterprise Value
10.13T 8.34T 5.33T 5.89T 8.84T
EV to EBITDA
18.13 17.54 9.48 13.08 26.90
EV to Sales
8.47 7.51 4.23 5.89 11.24
EV to Free Cash Flow
25.51 24.86 30.84 28.48 61.57
EV to Operating Cash Flow
21.84 20.35 21.84 21.06 43.13
Tangible Book Value Per Share
1.19K 976.00 850.71 709.21 581.78
Shareholders’ Equity Per Share
1.21K 988.07 866.00 722.57 596.31
Tax and Other Ratios
Effective Tax Rate
0.29 0.27 0.30 0.28 0.28
Revenue Per Share
726.88 675.52 766.02 608.07 478.84
Net Income Per Share
240.32 197.83 227.64 184.29 130.66
Tax Burden
0.71 0.73 0.70 0.72 0.72
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.15 0.16 0.12 0.14 0.15
SG&A to Revenue
0.00 0.00 0.02 0.03 0.03
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.17 1.26 0.42 0.59 0.60
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis